Postconditioning: From experimental proof to clinical concept

DMM Disease Models and Mechanisms

Volumn 3, Issue 1-2, 2010, Pages 39-44

  Mewton, Nathan ^a   Ivanès, Fabrice ^a   Cour, Martin ^a   Ovize, Michel ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CREATINE KINASE; CYCLOPHILIN D; CYCLOSPORIN A; CYCLOSPORIN A [4 N METHYLISOLEUCINE]; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; TROPONIN I;

ACUTE HEART INFARCTION; DRUG ACTIVITY; DRUG MECHANISM; ENZYME RELEASE; HEART INFARCTION SIZE; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; THROMBUS ASPIRATION; TREATMENT RESPONSE;

ANIMALS; HUMANS; MYOCARDIAL REPERFUSION INJURY; TRANSLATIONAL RESEARCH;

ANIMALIA;

EID: 77649223166     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.004309     Document Type: Note

References (41)

1. Argaud. L., Gateau-Roesch, O., Raisky, O., Loufouat, J., Robert, D. and Ovize, M. (2005a). Postconditioning inhibits mitochondrial permeability transition. Circulation 111, 194-197.
2. Argaud, L., Gomez, L., Gateau-Roesch, O., Couture-Lepetit, E., Loufouat, J., Robert, D. and Ovize, M. (2005b). Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. J. Mol. Cell Cardiol. 39, 893-899.
3. Argaud, L., Loufouat, J., Gateau-Roesch, O., Gomez, L., Robert, D. and Ovize, M. (2008). Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion. Shock 30, 552-556.
4. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W. et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662.
5. Boden, W. E., van Gilst, W. H., Scheldewaert, R. G., Starkey, I. R., Carlier, M. F., Julian, D. G., Whitehead, A., Bertrand, M. E., Col, J. J., Pedersen, O. L. et al. (2000). Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete infarction trial of European research collaborators evaluating prognosis post-thrombolysis (INTERCEPT). Lancet 355, 1751-1756.
6. Bopassa, J. C., Michel, P., Gateau-Roesch, O., Ovize, M. and Ferrera, R. (2005). Lowpressure reperfusion alters mitochondrial permeability transition. Am. J. Physiol. Heart Circ. Physiol. 288, H2750-H2755.
7. Bopassa, J. C., Ferrera. R., Gateau-Roesch, O., Couture-Lepetit, E. and Ovize, M. (2006). PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc. Res. 69, 178-185.
8. Cohen, M. V., Yang, X. M. and Downey, J. M. (2008). Acidosis., oxygen., and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res. Cardiol. 103, 464-471.
9. Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341, 233-249.
10. Di Lisa, F., Menabo, R., Canton, M., Barile, M. and Bernardi, P. (2001). Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571-2575.
11. Griffiths, E. J. and Halestrap, A. P. (1995). Mitochondrial non-specific pores remain closed during cardiac ischaemia., but open upon reperfusion. Biochem. J. 307, 93-98.
12. Halestrap, A. P., Clarke, S. J. and Javadov, S. A. (2004). Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc. Res. 61, 372-385.
13. Hausenloy, D. J. and Yellon, D. M. (2008). Preconditioning and postconditioning: Underlying mechanisms and clinical application. Atherosclerosis 204, 334-341.
14. Hausenloy, D. J., Maddock, H. L., Baxter, G. F. and Yellon, D. M. (2002). Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc. Res. 55, 534-543.
15. Jennings, R. B., Sommers, H. M., Smyth, G. A., Flack, H. A. and Linn, H. (1960). Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch. Pathol. 70, 68-78.
16. Kin, H., Zhao, Z. Q., Sun, H. Y., Wang, N. P., Corvera, J. S., Halkos, M. E., Kerendi, F., Guyton, R. A. and Vinten-Johansen, J. (2004). Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc. Res. 62, 74-85.
17. Kin, H., Zatta, A. J., Lofye, M. T., Amerson, B. S., Halkos, M. E., Kerendi, F., Zhao, Z. Q., Guyton, R. A., Headrick, J. P. and Vinten-Johansen, J. (2005). Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc. Res. 67, 124-133.
18. Klein, H. H., Pich, S., Lindert, S., Nebendahl, K., Warneke, G. and Kreuzer, H. (1989). Treatment of reperfusion injury with intracoronary calcium channel antagonists and reduced coronary free calcium concentration in regionally ischemic, reperfused porcine hearts. J. Am. Coll. Cardiol. 13, 1395-1401.
19. Kloner, R. A., Ganote, C. E. and Jennings, R. B. (1974). The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54, 1496-1508.
20. Kroemer, G., Dallaporta, B. and Resche-Rigon, M. (1998). The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642.
21. Leung, A. W. and Halestrap, A. P. (2008). Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim. Biophys. Acta. 1777, 946-952.
22. Lim, S. Y., Davidson, S. M., Hausenloy, D. J. and Yellon, D. M. (2007). Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc. Res. 75, 530-535.
23. McGovern, P. G., Pankow, J. S., Shahar, E., Doliszny, K. M., Folsom, A. R., Blackburn, H. and Luepker, R. V. (1996). Recent trends in acute coronary heart diseasemortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N. Engl. J. Med. 334, 884-890.
24. Murry, C. E., Jennings, R. B. and Reimer, K. A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
25. Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T. and Tsujimoto, Y. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658.
26. Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., Cung, T. T., Bonnefoy, E., Angoulvant, D. et al. (2008). Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359, 473-481.
27. Piper, H. M., Abdallah, Y. and Schafer, C. (2004). The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc. Res. 61, 365-371.
28. Rasola, A. and Bernardi, P. (2007). The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12, 815-833.
29. Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L'Huillier, I., Aupetit, J. F., Bonnefoy, E., Finet, G., André-Fouët, X. et al. (2005). Postconditioning the human heart. Circulation 112, 2143-2148.
30. Svilaas, T., Vlaar, P. J., van der Horst, I. C., Diercks, G. F., de Smet, B. J., van den Heuvel, A. F., Anthonio, R. L., Jessurun, G. A., Tan, E. S., Suurmeijer, A. J. et al. (2008). Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 358, 557-567.
31. Thibault, H., Piot, C., Staat, P., Bontemps, L., Sportouch, C., Rioufol, G., Cung, T. T., Bonnefoy, E., Angoulvant, D., Aupetit, J. F. et al. (2008). Long-term benefit of postconditioning. Circulation 117, 1037-1044.
32. Tsang, A., Hausenloy, D. J., Mocanu, M. M. and Yellon, D. M. (2004). Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res. 95, 230-232.
33. Vlaar, P. J., Svilaas, T., van der Horst, I. C., Diercks, G. F., Fokkema, M. L., de Smet, B. J., van den Heuvel, A. F., Anthonio, R. L., Jessurun, G. A., Tan, E. S. et al. (2008). Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371, 1915-1920.
34. Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S. and Lima, J. A. (1998). Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97, 765-772.
35. Yang, X. M., Proctor, J. B., Cui, L., Krieg, T., Downey, J. M. and Cohen, M. V. (2004). Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44, 1103-1110.
36. Yellon, D. M. and Hausenloy, D. J. (2007). Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121-1135.
37. Zhao, Z. Q., Corvera, J. S., Halkos, M. E., Kerendi, F., Wang, N. P., Guyton, R. A. and Vinten-Johansen, J. (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285, H579-H588.
38. Glickman, L. T., Raghavan, M., Knapp, D. W., Bonney, P. L. and Dawson, M. H. (2004). Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J. Am. Vet. Med. Assoc. 224, 1290-1297.
39. Goldschmidt, M. H. and Hendrick, M. J. (2002). Tumors of the skin and soft tissues. In: Tumors in Domestic Animals (ed. D. J. Meuten), pp. 45-118. Ames, Iowa: Blackwell Publishing Professional.
40. Hawkins, D. S. and Arndt, C. A. (2003). Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 98, 2447-2456.
41. Hayes, H. J. (1976). Canine bladder cancer: epidemiologic features. Am. J. Epidemiol. 104, 673-677.